Sign inGet started

Fink Jeffrey Arvin

Insider CIK 1595930 · LPCN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LPCN Lipocine Inc. A Award deriv2025-06-042025-06-051,764$3.20 $5.6K11,526SEC↗
LPCN Lipocine Inc. A Award deriv2024-06-052024-06-071,764$7.05 $12.4K10,938SEC↗
LPCN Lipocine Inc. A Award deriv2023-05-102023-05-1230,000$0.27 $8.1K166,000SEC↗
LPCN Lipocine Inc. A Award deriv2022-06-082022-06-1022,000$0.92 $20.2K136,000SEC↗
LPCN Lipocine Inc. A Award deriv2021-06-092021-06-1022,000$1.26 $27.7K22,000SEC↗
LPCN Lipocine Inc. M Exercise deriv2020-12-162020-12-175,625— $05,625SEC↗
LPCN Lipocine Inc. M Exercise2020-12-162020-12-175,625— $06,562SEC↗
LPCN Lipocine Inc. A Award deriv2020-06-102020-06-1022,000$0.96 $21.1K22,000SEC↗
LPCN Lipocine Inc. A Award deriv2019-06-122019-06-1410,000$1.68 $16.8K10,000SEC↗
LPCN Lipocine Inc. A Award deriv2018-06-272018-06-2820,000$1.33 $26.6K20,000SEC↗
LPCN Lipocine Inc. M Exercise deriv2017-12-292018-01-021,875— $05,625SEC↗
LPCN Lipocine Inc. S Sale2017-12-292018-01-02938$3.47 $3.3K937SEC↗
LPCN Lipocine Inc. M Exercise2017-12-292018-01-021,875— $01,875SEC↗
LPCN Lipocine Inc. A Award deriv2017-01-262017-01-307,500— $07,500SEC↗
LPCN Lipocine Inc. A Award deriv2016-06-142016-06-1710,000$8.02 $80.2K10,000SEC↗
LPCN Lipocine Inc. A Award deriv2015-06-162015-06-1720,000— $030,000SEC↗
LPCN Lipocine Inc. A Award deriv2014-01-062014-01-0710,000— $010,000SEC↗